Antiproton radiotherapy

Radiotherapy and Oncology

Volumn 86, Issue 1, 2008, Pages 14-19

  Bassler, Niels ^a,b   Alsner, Jan ^a   Beyer, Gerd ^c   DeMarco, John J ^d   Doser, Michael ^e   Hajdukovic, Dragan ^f   Hartley, Oliver ^c   Iwamoto, Keisuke S ^d   Jäkel, Oliver ^b   Knudsen, Helge V ^g   Kovacevic, Sandra ^f   Møller, Søren Pape ^h   Overgaard, Jens ^a   Petersen, Jørgen B ^a   Solberg, Timothy D ⁱ   Sørensen, Brita S ^a   Vranjes, Sanja ^j   Wouters, Bradly G ^k   Holzscheiter, Michael H ^l  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CERN   (Switzerland)

^f UNIVERSITY OF MONTENEGRO   (Montenegro)

^g Department of Physics and Astronomy ^*

^h AARHUS UNIVERSITY   (Denmark)

ⁱ UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^j UNIVERSITY OF BELGRADE   (Serbia)

^k MAASTRICHT UNIVERSITY   (Netherlands)

^l UNIVERSITY OF NEW MEXICO   (United States)

more..

Author keywords

Antiproton; Particle irradiation; RBE

Indexed keywords

ALANINE; CARBON; PROTON;

ARTICLE; BEAM THERAPY; CANCER RADIOTHERAPY; CHINESE HAMSTER; COMPUTER PROGRAM; DOSIMETRY; IMAGING SYSTEM; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; IONIZATION CHAMBER; LOW ENERGY RADIATION; MONTE CARLO METHOD; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION PHYSICS; TREATMENT PLANNING;

ANIMALS; ELEMENTARY PARTICLES; HUMANS; LINEAR ENERGY TRANSFER; MODELS, BIOLOGICAL; PROTONS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, HIGH-ENERGY; RELATIVE BIOLOGICAL EFFECTIVENESS;

EID: 38349091677     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.11.028     Document Type: Article

References (30)

1. Gray L., and Kalogeropoulos T.E. Possible biomedical applications of antiproton beams: focused radiation transfer. Radiat Res (1984) 246-252
2. Sullivan A.H. A measurement of the local energy deposition by antiprotons coming to rest in tissue-like material. Phys Med Biol 30 (1985) 1297-1303
3. Goitein M., and Goitein G. Swedish protons. Acta Oncologica 44 (2005) 793-797
4. Olsen D.R., Bruland Ø.S., Frykholm G., and Norderhaug I.N. Proton therapy - A systematic review of clinical effectiveness. Radiother Oncol 83 (2007) 123-132
5. Jäkel O., Schulz-Ertner D., Karger C.P., Nikoghosyan A., and Debus J. Heavy ion therapy: status and perspectives. Technol Cancer Res Treat 2 (2003) 377-387
6. Schulz-Ertner D., Jäkel O., and Schlegel W. Radiation therapy with charged particles. Semin Radiat Oncol 16 (2006) 249-259
7. Schulz-Ertner D., and Tsujii H. Particle radiation therapy using proton and heavier ion beams. J Clin Oncol 25 (2007) 953-964
8. Budach V. The role of fast neutrons in radiooncology - A critical appraisal. Strahlenther Onkol 167 (1991) 677-692
9. Wisser L. Pion treatment of prostate carcinoma at Paul Scherrer Institute (formerly Swiss Institute for Nuclear Research (SIN)) from 1983 to 1992. Cancer Radiothérapie 8 (2004) 88-94
10. Bassler N, Holzscheiter M, Knudsen H, The AD4/ACE Collaboration. Cancer therapy with antiprotons. In: Dieter Grzonka, Rafał Czyżykiewicz, Walter Oelert, Thomasz Rożek, Peter Winter, editors. Low Energy Antiproton Physics-LEAP '05, vol. CP796 of AIP Conference Proceedings. American Institute of Physics, 2005; pp. 423-430.
11. Ponomarev L.I. Molecular structure effects on atomic and nuclera capture of mesons. Annu Rev Nucl Sci (1973) 395-430
12. Agnew Jr. L.E., Elioff T., Fowler W.B., Lander R.L., Powell W.M., Segrè E., et al. Antiproton interactions in hydrogen and carbon below 200 MeV. Phys Rev (1960) 1371-1391
13. Inokuti M. Interactions of antiprotons with atoms and molecules. Nucl Tracks Radiat Meas 16 (1989) 115-123
14. Cugnon J., Wycech S., Jastrzȩbski J., and Lubiński P. Geometrical effects in antiproton annihilation on nuclei. Phys Rev C 63 (2001) 027301
15. Markiel W., Daniel H., von Egidy T., Hartmann F.J., Hofmann P., Kanert W., et al. Emission of helium ions after antiproton annihiliation in nuclei. Nuclear Physics A 485 (1988) 445-460
16. Polster D., Hilscher D., Rossner H., von Egidy T., Harmann F.J., Hoffmann J., et al. Light particle emission induced by stopped antiprotons in nuclei: energy dissipation and neutron-to-proton ratio. Phys Rev C 51 (1995) 1167-1180
17. Holzscheiter M.H., Bassler N., Agazaryan N., Beyer G., Blackmore E., DeMarco J.J., et al. The biological effectiveness of antiproton irradiation. Radiother Oncol 81 (2006) 233-242
18. Fassò A, Ferrari A, Ranft J, Sala PR. FLUKA: a multi-particle transport code. CERN-2005-10, INFN/TC_05/11, SLAC-R-773.
19. The physics models of FLUKA: status and recent developments, La Jolla, CA, USA, 2003. (paper MOMT005), eConf C0303241 (2003), arXiv:hep-ph/0306267.
20. Hansen J.W., Olsen K.J., and Wille M. The alanine radiation detector for high and low LET dosimetry. Radiat Prot Dosimetry 19 (1987) 43-47
21. Palmans H. Effect of alanine energy response and phantom material on depth dose measurements in ocular protons beams. Technol Cancer Res Treat 2 (2003) 579-586
22. Niels Bassler. Experimental studies relevant for antiproton cancer therapy. Ph.D. thesis, Aarhus University, 2006.
23. Boag J.W., and Currant J. Current collection and ionic recombination in small cylindrical ionization chambers exposed to pulsed radiation. Brit J Radiol 53 (1980) 471-478
24. Kanai T., Sudo M., Matsufujii N., and Futami Y. Initial recombination in a parallel-plate ionization chamber exposed to heavy ions. Phys Med Biol 43 (1998) 3549-3558
25. Gudowska I., Sobolevsky N., Andreo P., Belkic̀ D., and Brahme A. Ion beam transport in tissue-like media using the monte carlo code SHIELD-HIT. Phys Med Biol 49 (2004) 1933-1958
26. Krämer M., Jäkel O., Haberer T., Kraft G., Schardt D., and Weber U. Treatment planning for heavy-ion radiotherapy physical beam model and dose optimization. Phys Med Biol 45 (2000) 3299-3317
27. Krämer M., and Scholz M. Treatment planning for heavy-ion radiotherapy calculation and optimization of biologically effective dose. Phys Med Biol 45 (2000) 3319-3330
28. Scholz M. Grundlagen der biologischen Bestrahlungsplanung fur die Schwerionen-Tumortherapie. Medizinische Fakultat Heidelberg, Ruprecht-Karls-Universität. Habilitationsschrift. (In German).
29. Scholz M., and Kraft G. Track structure and the calculation of biological effects of heavy charged particles. Adv Space Res 18 (1995) 5-14
30. Scholz M., Kellerer A.M., and Kraft-Weyrather W. Computation of cell survival in heavy ion beams for therapy. Radiat Environ Biophys 36 (1997) 59-66